{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:06:35Z","timestamp":1767211595183,"version":"build-2065373602"},"reference-count":100,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>The landscape of human immunodeficiency virus (HIV) epidemiology and treatment is ever-changing, with the widespread and evolving use of antiretroviral therapy (ART). With timely ART, people living with HIV (PLWH) are nearing the life expectancies and the functionality of the general population; nevertheless, the effects of HIV and ART on cardiovascular health remain under investigation. The pathophysiology of HIV-related cardiomyopathy and heart failure (HF) have historically been attributed to systemic inflammation and changes in cardiometabolic function and cardiovascular architecture. Importantly, newer evidence suggests that ART also plays a role in modulating the process of HIV-related cardiomyopathy and HF. In the short term, newer highly active ART (HAART) seems to have cardioprotective effects; however, emerging data on the long-term cardiovascular outcomes of certain HAART medications, i.e., protease inhibitors, raise concerns about the potential adverse effects of these drugs in the clinical course of HIV-related HF. As such, the traditional phenotypes of dilated cardiomyopathy and left ventricular systolic failure that are associated with HIV-related heart disease are incrementally being replaced with increasing rates of diastolic dysfunction and ischemic heart disease. Moreover, recent studies have found important links between HIV-related HF and other clinical and biochemical entities, including depression, which further complicate cardiac care for PLWH. Considering these trends in the era of ART, the traditional paradigms of HIV-related cardiomyopathy and HF are being called into question, as is the therapeutic role of interventions such as ventricular assist devices and heart transplantation. In all, the mechanisms of HIV-related myocardial damage and the optimal approaches to the prevention and the treatment of cardiomyopathy and HF in PLWH remain under investigation.<\/jats:p>","DOI":"10.3390\/jpm12111760","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T21:09:17Z","timestamp":1666645757000},"page":"1760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Human Immunodeficiency Virus Infection-Associated Cardiomyopathy and Heart Failure"],"prefix":"10.3390","volume":"12","author":[{"given":"Aikaterini","family":"Papamanoli","sequence":"first","affiliation":[{"name":"Internal Medicine, Zucker School of Medicine, Northwell Health at Mather Hospital, Port Jefferson, NY 11777, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-2673","authenticated-orcid":false,"given":"Brandon","family":"Muncan","sequence":"additional","affiliation":[{"name":"Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanwoo","family":"Yoo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Albany Medical Center, Albany, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Psevdos","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Northport Veterans Affairs, Northport, NY 11768, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-429X","authenticated-orcid":false,"given":"Andreas P.","family":"Kalogeropoulos","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Stony Brook University Medical Center, 101 Nicolls Road, Health Science Center T-16, Rm. 080, Stony Brook, NY 11794, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe","volume":"11","author":"Wandeler","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global Burden of Atherosclerotic Cardiovascular Disease in People Living with HIV","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574","article-title":"Heart failure in patients with human immunodeficiency virus infection: Epidemiology, pathophysiology, treatment, and future research","volume":"129","author":"Remick","year":"2014","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e012241","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database","volume":"8","author":"Alonso","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e009985","DOI":"10.1161\/JAHA.118.009985","article-title":"Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women","volume":"7","author":"Feinstein","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: A modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","unstructured":"OMS (2022, September 25). UNAIDS-Global HIV & AIDS Statistics\u20142020 Fact Sheet. Available online: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00002030-200304001-00004","article-title":"Immunopathogenesis of HIV-related heart muscle disease","volume":"17","author":"Currie","year":"2003","journal-title":"AIDS"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/aid.1998.14.1071","article-title":"Cardiac Involvement in the Acquired Immunodeficiency Syndrome: A Multicenter Clinical-Pathological Study","volume":"14","author":"Barbaro","year":"1998","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jchf.2015.05.003","article-title":"Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries","volume":"3","author":"Bloomfield","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jchf.2018.10.006","article-title":"Cardiac Dysfunction among People Living with HIV","volume":"7","author":"Erqou","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HCO.0000000000000513","article-title":"Heart health in the age of highly active antiretroviral therapy","volume":"33","author":"Belkin","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cardfail.2019.10.011","article-title":"Diastolic Dysfunction in Patients with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results from the CHART Study","volume":"26","author":"Butler","year":"2019","journal-title":"J. Card. Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/QAI.0000000000002629","article-title":"Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies","volume":"87","author":"Chen","year":"2021","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/pcad.2000.9031","article-title":"Cardiomyopathy in AIDS: A pathophysiological perspective","volume":"43","author":"Lewis","year":"2000","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9746","DOI":"10.1038\/s41598-020-65943-9","article-title":"HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice","volume":"10","author":"Dash","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.100.9.933","article-title":"Intensity of Myocardial Expression of Inducible Nitric Oxide Synthase Influences the Clinical Course of Human Immunodeficiency Virus-Associated Cardiomyopathy","volume":"100","author":"Barbaro","year":"1999","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM199810153391601","article-title":"Incidence of Dilated Cardiomyopathy and Detection of HIV in Myocardial Cells of HIV-Positive Patients","volume":"339","author":"Barbaro","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV Infection and the Risk of Heart Failure with Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/infdis\/jiz252","article-title":"Plasma Biomarkers of Human Immunodeficiency Virus\u2013Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy","volume":"220","author":"Kroeze","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/infdis\/jiu809","article-title":"Hospitalization Rates and Reasons among HIV Elite Controllers and Persons with Medically Controlled HIV Infection","volume":"211","author":"Crowell","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/QAD.0b013e3282f57f61","article-title":"Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNF\u03b1","volume":"22","author":"Yearley","year":"2008","journal-title":"AIDS"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/infdis\/jiy183","article-title":"Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy","volume":"218","author":"Schuster","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e004091","DOI":"10.1161\/CIRCIMAGING.115.004091","article-title":"Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients","volume":"9","author":"Luetkens","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e004430","DOI":"10.1161\/CIRCIMAGING.115.004430","article-title":"HIV-1\u2013Related Cardiovascular Disease Is Associated with Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema","volume":"9","author":"Ntusi","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1038\/s41598-019-44300-5","article-title":"Pulmonary hypertension in the global population of adolescents and adults living with HIV: A systematic review and meta-analysis","volume":"9","author":"Bigna","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cjca.2019.01.005","article-title":"Pulmonary Hypertension in HIV","volume":"35","author":"Basyal","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1513\/pats.201006-046WR","article-title":"Pathogenesis of HIV-Associated Pulmonary Hypertension: Potential Role of HIV-1 nef","volume":"8","author":"Almodovar","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"H731","DOI":"10.1152\/ajpheart.00549.2019","article-title":"HIV-related cardiovascular diseases: The search for a unifying hypothesis","volume":"318","author":"Dominick","year":"2020","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cardfail.2014.03.009","article-title":"Isolated Right Ventricular Dysfunction in Patients with Human Immunodeficiency Virus","volume":"20","author":"Simon","year":"2014","journal-title":"J. Card. Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardfail.2018.08.010","article-title":"Right Ventricular Hypertrophy and Dilation in Patients with Human Immunodeficiency Virus in the Absence of Clinical or Echocardiographic Pulmonary Hypertension","volume":"24","author":"Ceran","year":"2018","journal-title":"J. Card. Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/18734251MTAyoOTM05","article-title":"Cardiovascular Risk Assessment in People Living with HIV: A Systematic Review and Meta-Analysis of Real-Life Data","volume":"18","author":"Bia","year":"2020","journal-title":"Curr. HIV Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2015.03.019","article-title":"High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis","volume":"240","author":"Cerrato","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: Mechanisms and management","volume":"16","author":"Hsue","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV Infection and the Risk of Acute Myocardial Infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","article-title":"Outcomes After Acute Myocardial Infarction in HIV-Infected Patients","volume":"127","author":"Lorgis","year":"2013","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pcad.2020.01.002","article-title":"Epidemiology, pathophysiology, and prevention of heart failure in people with HIV","volume":"63","author":"Sinha","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"ofy086","DOI":"10.1093\/ofid\/ofy086","article-title":"Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data from Clinical Trials","volume":"5","author":"Nan","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study","volume":"201","author":"Worm","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2018.04.083","article-title":"Protease Inhibitors and Cardiovascular Outcomes in Patients with HIV and Heart Failure","volume":"72","author":"Alvi","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126315","DOI":"10.1172\/jci.insight.126315","article-title":"Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies","volume":"4","author":"Brayson","year":"2019","journal-title":"JCI Insight"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/infdis\/jiz481","article-title":"Is the Risk of Myocardial Infarction in People with Human Immunodeficiency Virus (HIV) Associated with Atazanavir or Darunavir? A Nested Case-Control Study within the French Hospital Database on HIV","volume":"221","author":"Costagliola","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/faat.1993.1046","article-title":"Acute cardiotoxicity of nucleoside analogs FddA and FddI in rats","volume":"20","author":"Comereski","year":"1993","journal-title":"Fundam. Appl. Toxicol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/labinvest.3780022","article-title":"Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine","volume":"80","author":"Lewis","year":"2000","journal-title":"Lab. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/labinvest.3780288","article-title":"Mitochondrial DNA Depletion, Oxidative Stress and Mutation: Mechanisms of Nucleoside Reverse Transcriptase Inhibitor Toxicity","volume":"81","author":"Lewis","year":"2001","journal-title":"Lab. Investig. A J. Tech. Methods Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ymeth.2009.12.013","article-title":"Transgenic mouse models of mitochondrial toxicity associated with HIV\/AIDS and antiretrovirals","volume":"51","author":"Koczor","year":"2010","journal-title":"Methods"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.114.014443","article-title":"Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort Study","volume":"132","author":"White","year":"2015","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1995-705X.107117","article-title":"Peripartum cardiomyopathy coexistent with human immunodeficiency virus: A substantial obstetric jeopardy","volume":"14","author":"Mandal","year":"2013","journal-title":"Heart Views Off. J. Gulf Heart Assoc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijcard.2009.08.022","article-title":"Long-term outcome of Peripartum cardiomyopathy in a population with high seropositivity for Human Immunodeficiency Virus","volume":"147","author":"Sliwa","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijcard.2010.12.047","article-title":"HIV infection is not associated with echocardiographic signs of cardiomyopathy or pulmonary hypertension among pregnant Ugandan women","volume":"147","author":"Longenecker","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/pd.4549","article-title":"Fetal cardiac biometry and function in HIV-infected pregnant women exposed to HAART therapy","volume":"35","author":"Rodriguez","year":"2015","journal-title":"Prenat. Diagn."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Otero, L., L\u00f3pez, M., Guitart-Mampel, M., Mor\u00e9n, C., Gonc\u00e9, A., Esteve, C., Salazar, L., G\u00f3mez, O., Mart\u00ednez, J.M., and Torres, B. (2019). Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213279"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccl.2017.09.005","article-title":"A New Face of Cardiac Emergencies","volume":"36","author":"Tsabedze","year":"2018","journal-title":"Cardiol. Clin."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/QAI.0b013e318163bd70","article-title":"Venous Thromboembolism in Patients with HIV\/AIDS","volume":"48","author":"Streiff","year":"2008","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1056\/NEJMoa1914279","article-title":"Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV","volume":"384","author":"Tseng","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e004312","DOI":"10.1161\/CIRCHEARTFAILURE.117.004312","article-title":"Association of Biomarker Clusters with Cardiac Phenotypes and Mortality in Patients with HIV Infection","volume":"11","author":"Scherzer","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: A novel mediator of heart failure development and progression","volume":"11","author":"Voors","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1097\/QAD.0000000000001186","article-title":"Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals","volume":"30","author":"Fitch","year":"2016","journal-title":"AIDS"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cjca.2013.12.010","article-title":"Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients with Heart Failure with Preserved Ejection Fraction","volume":"30","author":"Izumiya","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jchf.2015.03.007","article-title":"Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals","volume":"3","author":"Secemsky","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"59B","DOI":"10.1016\/j.amjcard.2015.01.042","article-title":"Structural Heart Disease and ST2: Cross-Sectional and Longitudinal Associations with Echocardiography","volume":"115","author":"Defilippi","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2010.159277","article-title":"Prognostic Utility of ST2 in Patients with Acute Dyspnea and Preserved Left Ventricular Ejection Fraction","volume":"57","author":"Shah","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/ehf2.12849","article-title":"Elevated N-terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri-urban township","volume":"7","author":"Peterson","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1310\/U9LJ-MFF9-ARE1-257H","article-title":"Matrix Metalloproteinase-9 and Tissue Inhibitors of Matrix Metalloproteinase-1 in Plasma of Patients Co-Infected with HCV and HIV","volume":"3","author":"Mastroianni","year":"2002","journal-title":"HIV Clin. Trials"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2004.07.023","article-title":"Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression","volume":"44","author":"Polyakova","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e013522","DOI":"10.1161\/JAHA.119.013522","article-title":"Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women with or at Risk for HIV Infection: The Women\u2019s Interagency HIV Study","volume":"9","author":"Bravo","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5830\/CVJA-2016-067","article-title":"Presentation and mortality of patients hospitalised with acute heart failure in Botswana","volume":"28","author":"Mwita","year":"2017","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2018.03.110","article-title":"Incidence and predictors of 6 months mortality after an acute heart failure event in rural Uganda: The Mbarara Heart Failure Registry (MAHFER)","volume":"264","author":"Abeya","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1161\/HYPERTENSIONAHA.120.16263","article-title":"Antihypertensive Class and Cardiovascular Outcomes in Patients with HIV and Hypertension","volume":"77","author":"Rethy","year":"2021","journal-title":"Hypertension"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"103270","DOI":"10.1016\/j.ebiom.2021.103270","article-title":"LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy","volume":"65","author":"Planas","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/infdis\/jiaa259","article-title":"Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial","volume":"222","author":"Fichtenbaum","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/09540120020014264","article-title":"Injecting drug users\u2019 adherence to HIV antiretroviral treatments: Physicians\u2019 beliefs","volume":"12","author":"Escaffre","year":"2000","journal-title":"AIDS Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1468-1293.2011.00919.x","article-title":"Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy","volume":"12","author":"Yehia","year":"2011","journal-title":"HIV Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1056\/NEJMp030074","article-title":"Responding to Organ Failure in HIV-Infected Patients","volume":"348","author":"Roland","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_77","first-page":"21","article-title":"An Update on Heart Transplantation in Human Immunodeficiency Virus\u2013Infected Patients","volume":"16","author":"Castel","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_78","first-page":"611","article-title":"HIV infection after heart transplantation: A case report","volume":"10","author":"Anthuber","year":"1991","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2009.04.005","article-title":"Heart Transplantation in Human Immunodeficiency Virus\u2013Positive Patients","volume":"28","author":"Uriel","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.healun.2011.07.022","article-title":"Heart transplantation in HIV-infected patients: More cases in Europe","volume":"30","author":"Castel","year":"2011","journal-title":"J. Heart Lung Transplant."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1432-2277.2007.00483.x","article-title":"Effects of immunosuppressive drugs on HIV infection: Implications for solid-organ transplantation","volume":"20","author":"Ciuffreda","year":"2007","journal-title":"Transpl. Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2011.03.004","article-title":"Human immunodeficiency virus infection and left ventricular assist devices: A case series","volume":"30","author":"Sims","year":"2011","journal-title":"J. Heart Lung Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.healun.2014.04.015","article-title":"Advanced heart failure in patients infected with human immunodeficiency virus: Is there equal access to care?","volume":"33","author":"Uriel","year":"2014","journal-title":"J. Heart Lung Transplant."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.smj.0000202698.25909.97","article-title":"Reversible Right Ventricular Dysfunction in Patients with HIV Infection","volume":"99","author":"Rangasetty","year":"2006","journal-title":"South. Med. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1017\/S1047951103000763","article-title":"Reversible cardiomyopathy subsequent to perinatal infection with the human immunodeficiency virus","volume":"13","author":"Carvalho","year":"2003","journal-title":"Cardiol. Young"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/QAD.0b013e3283578bfa","article-title":"The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1","volume":"26","author":"Patel","year":"2012","journal-title":"AIDS"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.CIR.92.8.2220","article-title":"Immunoglobulins and Left Ventricular Structure and Function in Pediatric HIV Infection","volume":"92","author":"Lipshultz","year":"1995","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jchf.2019.12.007","article-title":"Heart Failure Outcomes and Associated Factors among Veterans with Human Immunodeficiency Virus Infection","volume":"8","author":"Erqou","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of Causes of Death and Mortality Rates among HIV-Infected Persons","volume":"41","author":"Crum","year":"2006","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","article-title":"Sudden Cardiac Death in Patients with Human Immunodeficiency Virus Infection","volume":"59","author":"Tseng","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jchf.2019.04.025","article-title":"The Risk for Sudden Cardiac Death among Patients Living with Heart Failure and Human Immunodeficiency Virus","volume":"7","author":"Alvi","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jchf.2019.06.007","article-title":"Presumed Sudden Cardiac Deaths among Persons with HIV and Heart Failure","volume":"7","author":"Tseng","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.amjcard.2019.07.034","article-title":"Human Immunodeficiency Virus Infection and Risk of Heart Failure Rehospitalizations","volume":"124","author":"Brouch","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2016.05.027","article-title":"Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities","volume":"218","author":"ElAmm","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e001035","DOI":"10.1161\/JAHA.114.001035","article-title":"HIV Infection and Cardiovascular Disease in Women","volume":"3","author":"Womack","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jacc.2016.11.013","article-title":"HIV Infection and Heart Failure Outcomes in Women","volume":"69","author":"Janjua","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, Prevention, and Management of Cardiovascular Disease in People Living with HIV: A Scientific Statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"ref_99","first-page":"1315","article-title":"Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction among Aging Women with Human Immunodeficiency Virus","volume":"221","author":"Zanni","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"19516","DOI":"10.7448\/IAS.17.4.19516","article-title":"Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study","volume":"17","author":"Hatleberg","year":"2014","journal-title":"J. Int. AIDS Soc."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/11\/1760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:02:00Z","timestamp":1760144520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/11\/1760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":100,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["jpm12111760"],"URL":"https:\/\/doi.org\/10.3390\/jpm12111760","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2022,10,24]]}}}